EMPAGLIFLOZIN Drug Record

  • EMPAGLIFLOZIN chembl:CHEMBL2107830 Approved

    Alternate Names:

    EMPAGLIFLOZIN
    JARDIANCE
    BI 10773
    BI-10773
    1-CHLORO-4-(GLUCOPYRANOS-1-YL)-2-(4-(TETRAHYDROFURAN-3-YLOXY)BENZYL)BENZENE
    BI10773
    (1S)-1,5-ANHYDRO-1-(4-CHLORO-3-{4-[(3S)-TETRAHYDROFURAN-3-YLOXY]BENZYL}PHENYL)-D-GLUCITOL
    (1S)-1,5-ANHYDRO-1-C-{4-CHLORO-3-((4-{((3S)-OXOLAN-3-YL)OXY}PHENYL)METHYL)PHENYL}-D-GLUCITOL
    chemidplus:864070-44-0
    pubchem.compound:11949646
    drugbank:09038
    chembl:CHEMBL2107830
    rxcui:1545653

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antidiabetic
    (0 More Sources)

    Publications:

  • EMPAGLIFLOZIN   SLC5A2

    Interaction Score: 7.73

    Interaction Types & Directionality:
    antagonist (inhibitory)
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name BI-10773
    Novel drug target Established target
    Mechanism of Interaction Sodium/glucose cotransporter 2 inhibitor

    PMIDs:
    25598831


    Sources:
    TdgClinicalTrial ChemblInteractions

  • EMPAGLIFLOZIN   SLC5A4

    Interaction Score: 3.43

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD